Compare FDMT & FTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FDMT | FTK |
|---|---|---|
| Founded | 2013 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 515.6M | 522.1M |
| IPO Year | 2019 | 1997 |
| Metric | FDMT | FTK |
|---|---|---|
| Price | $9.49 | $15.70 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 1 |
| Target Price | ★ $31.71 | $20.00 |
| AVG Volume (30 Days) | ★ 783.4K | 211.2K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 18.79 | ★ 147.06 |
| EPS | N/A | ★ 0.84 |
| Revenue | $85,209,000.00 | ★ $136,092,000.00 |
| Revenue This Year | N/A | $13.33 |
| Revenue Next Year | $70.28 | $16.38 |
| P/E Ratio | ★ N/A | $18.65 |
| Revenue Growth | ★ 230194.60 | 214.53 |
| 52 Week Low | $2.89 | $6.20 |
| 52 Week High | $12.34 | $20.41 |
| Indicator | FDMT | FTK |
|---|---|---|
| Relative Strength Index (RSI) | 50.20 | 50.03 |
| Support Level | $8.41 | $15.89 |
| Resistance Level | $9.78 | $18.46 |
| Average True Range (ATR) | 0.64 | 0.75 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 41.98 | 50.90 |
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).
Flotek Industries Inc is a technology-driven specialty chemistry and data company. It has two reportable segments: Its Chemistry Technologies segment includes specialty chemistries, logistics and technology services. It also include integrated oil and gas companies, oilfield services companies, independent oil and gas companies, national and state-owned oil companies, and international supply chain management companies. The Data Analytics segment provides analytical measurement solutions and deliver real-time information and insights to customers to enable optimization of operations and reduction of emissions and their carbon intensity. Key revenue comes from its Chemistry Technologies segment.